Anthropometry (3)
- BMI - Body mass index (phv00483523.v1.p1)
- BODY_WEIGHT - Body weight of patient (phv00483524.v1.p1)
- WAIST - Waist circumference of Subjects (phv00483554.v1.p1)
Biomarkers (13)
- CHOLESTEROL_LDL - LDL/cholesterol ratio in blood (phv00483529.v1.p1)
- CREATININE - Creatinine content in blood (phv00483530.v1.p1)
- DBP - Diastolic blood pressure (phv00483531.v1.p1)
- eGFR - Estimated glomerular filtration rate (phv00483535.v1.p1)
- FASTING_GLUCOSE - Fasting blood glucose (phv00483536.v1.p1)
- HBA1C - Hemoglobin a1c (phv00483539.v1.p1)
- HR - Heart rate (phv00483540.v1.p1)
- MICROALBUMINURIA - Subjects with microalbuminuria (phv00483544.v1.p1)
- PP - Pulse pressure (phv00483547.v1.p1)
- SBP - Systolic blood pressure (phv00483549.v1.p1)
- TOTAL_CHOLESTEROL - Total cholesterol content in blood (phv00483551.v1.p1)
- TRIGLYCERIDES - Content of triglycerides in blood (phv00483552.v1.p1)
- UACR - Urinary albumin creatinine ratio (phv00483553.v1.p1)
Demographics (3)
- AGE - Age of subject (phv00483517.v1.p1)
- GENDER - Sex of subject (phv00483538.v1.p1)
- SEX - Biological sex (phv00483513.v1.p1)
Disease Events (5)
- AFFECTION_STATUS - Case control status of the subject for NTN, HTN, MetS, or CKD (phv00483518.v1.p1)
- CENTRAL_OBESITY - Subjects with central obesity (phv00483527.v1.p1)
- DIABETES - Subjects with diabetes (phv00483532.v1.p1)
- DYSLIPIDEMIA - Subjects with dyslipidemias (phv00483534.v1.p1)
- OBESITY - Subjects with obesity (phv00483546.v1.p1)
Medications (13)
- ALPHA2-AGONIST - Subjects consumed alpha2-adrenergic receptor agonists (phv00483519.v1.p1)
- ARBs - Subjects consumed angiotensin receptor type 1 blocker (phv00483520.v1.p1)
- ASA - Subjects consumed acetylsalicylic acid (phv00483521.v1.p1)
- BETA-BLOCKERS - Subjects consumed beta-adrenergic receptor blockers (phv00483522.v1.p1)
- CAI - Subjects consumed cholesterol-absorption inhibitors (phv00483525.v1.p1)
- CCBs - Subjects consumed calcium channel blockers (phv00483526.v1.p1)
- DIURETICS - Subjects consumed diuretics (phv00483533.v1.p1)
- FIBRATES - Subjects consumed fibrates (phv00483537.v1.p1)
- INSULIN - Subjects consumed insulin (phv00483541.v1.p1)
- INSULIN_SECRETAGOGUES - Subjects consumed insulin secretagogues (phv00483542.v1.p1)
- INSULIN_SENSITIZES - Subjects consumed insulin sensitizes (phv00483543.v1.p1)
- MRB - Subjects consumed mineralocorticoid receptor blocker (phv00483545.v1.p1)
- STATINS - Subjects consumed statins (phv00483550.v1.p1)
Race and Ethnicity (1)
- RACE - Race of subject (phv00483548.v1.p1)
Other (12)
- ANALYTE_TYPE - Analyte Type (phv00483557.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00483556.v2.p1)
- CHOLESTEROL_HDL - HDL/cholesterol ratio in blood (phv00483528.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00483560.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00483512.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00483559.v2.p1)
- IS_TUMOR - Tumor status (phv00483558.v2.p1)
- SAMPLE_ID - Sample ID (phv00483555.v2.p1)
- SAMPLE_ID - Identification number of RNA sample (phv00483515.v2.p1)
- SUBJECT_ID - ID of subject (phv00483516.v1.p1)
- SUBJECT_ID - Subject ID (phv00483511.v1.p1)
- SUBJECT_ID - Identification number of patient (phv00483514.v2.p1)